| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA217846
Max Phase: Preclinical
Molecular Formula: C19H25N3O3S
Molecular Weight: 375.49
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(CCCCCCSc1nc(O)cc(CCc2ccccc2)n1)NO
Standard InChI: InChI=1S/C19H25N3O3S/c23-17(22-25)10-6-1-2-7-13-26-19-20-16(14-18(24)21-19)12-11-15-8-4-3-5-9-15/h3-5,8-9,14,25H,1-2,6-7,10-13H2,(H,22,23)(H,20,21,24)
Standard InChI Key: QCVQAJUNQSWWLY-UHFFFAOYSA-N
Associated Targets(non-human)
Histone deacetylase HD2 351 Activities
Histone deacetylase HD1B 86 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 375.49 | Molecular Weight (Monoisotopic): 375.1617 | AlogP: 3.52 | #Rotatable Bonds: 11 |
| Polar Surface Area: 95.34 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.91 | CX Basic pKa: 1.68 | CX LogP: 4.48 | CX LogD: 4.47 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.18 | Np Likeness Score: -0.95 |
References
| 1. Mai A, Massa S, Rotili D, Simeoni S, Ragno R, Botta G, Nebbioso A, Miceli M, Altucci L, Brosch G.. (2006) Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors., 49 (20): [PMID:17004718] [10.1021/jm0605536] |
Source
Source(1):